Skip to content

Bone Healing at Non-submerged Implants Installed With Different Insertion Torques.

Bone Healing at Non-submerged Implants Installed With Different Insertion Torques. A Split Mouth Histomorphometric Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04017156
Enrollment
24
Registered
2019-07-12
Start date
2016-07-20
Completion date
2017-10-17
Last updated
2019-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edentulous; Alveolar Process, Atrophy

Brief summary

The objective of the study is to evaluate histomorphometrically the healing at implants installed with standard or very low insertion torque values.

Detailed description

Very high insertion torque values have been recommended when immediate loading is applied to implants.1 However, it has been shown that similar clinical outcomes may be achieved even with insertion torque values ≤15 Ncm when implants are splinted together. Due to the contradictory outcomes on the influence of the torque on osseointegration and a lack of histological data in humans, there is a need of more evidences that may support the clinicians in the decision making when an unintentional low insertion torque occur at implants during the daily practice. So the aim of the study i evaluate histomorphometrically the healing at implants installed in Twelve volunteer patients that will be recruited. Two screw-shaped titanium devices will be installed in the distal segments of the mandible using insertion torque values of either \<10 Ncm or \ 30 Ncm. The implants were left to heal in a non-submerged fashion. After 8 weeks, biopsies will be retrieved and ground sections will be prepared for histological evaluation.

Interventions

PROCEDUREimplant installation

All site preparations will be performed deeper compared to the length of the implant so that the implant apex cannot reach the bottom of the osteotomy.

Sponsors

ARDEC Academy
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The two recipient sites will be selected prior the surgery, while the type of site preparation will be randomly decided. The randomization will be performed electronically (randomization.com) by a researcher neither involved in the selection of the patients nor in installation of the devices (DB). Sealed opaque envelopes will be prepared and opened at the time of surgery by an author not involved in the surgery (DB). Surgeon and patients will be blinded.

Intervention model description

Clinical Trial

Eligibility

Sex/Gender
ALL
Age
25 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* presence of at least two edentulous zone in the posterior segment of the mandible * ≥ 25 years of age * smoking ≤ 10 cigarettes per day * Good general health * No contraindication for oral surgical procedures. * Not being pregnant.

Exclusion criteria

* Presence of systemic disorders * Chemotherapy or radiotherapy; * Smokers \>10 cigarettes per day * Previous bone augmentation procedures in the region

Design outcomes

Primary

MeasureTime frameDescription
New bone in contact with the implant surfaceAfter 8 weeks of healingThe percentages of new bone will be evaluated both in contact with the implant surface

Secondary

MeasureTime frameDescription
Bone density around the implant surfaceAfter 8 weeks of healingThe total mineralized bone will be assessed as sum of new and old bone

Other

MeasureTime frameDescription
pre-existing (old) bone, soft tissue (marrow spaces, Haversian canals, BMUs canals), bone debris/ clot remnants, and marrow spaces (soft tissue)After 8 weeks of healingThe percentages of pre-existing (old) bone, soft tissue (marrow spaces, Haversian canals, BMUs canals), bone debris/ clot remnants, and marrow spaces (soft tissue) will be evaluated all in contact with the implant surface

Countries

Colombia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026